In this study, we investigated the potential use of circulating activated TPH cells and activated CD8 T cells, both expressing PD1 and CD38, to look for residual disease activity of AIH and predict relapse after IS treatment withdrawal. The gene discussed is CD8A; the disease is autoimmune hepatitis.